001     868439
005     20210130004219.0
024 7 _ |a 10.1093/neuonc/noz236
|2 doi
024 7 _ |a 1522-8517
|2 ISSN
024 7 _ |a 1523-5866
|2 ISSN
024 7 _ |a 2128/24497
|2 Handle
024 7 _ |a altmetric:73085917
|2 altmetric
024 7 _ |a pmid:31859354
|2 pmid
024 7 _ |a WOS:000522636300005
|2 WOS
037 _ _ |a FZJ-2020-00033
082 _ _ |a 610
100 1 _ |a Langen, Karl-Josef
|0 P:(DE-Juel1)131777
|b 0
|e Corresponding author
|u fzj
245 _ _ |a Combined FET PET/ADC mapping: improved imaging of glioma infiltration?
260 _ _ |a Oxford
|c 2020
|b Oxford Univ. Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1583498637_27455
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Conventional MRI is the method of choice for the diagnosis of cerebral gliomas owing to its ability to detect structural changes with high spatial resolution and outstanding sensitivity. In malignant gliomas, the determination of tumor extent is primarily based on the assessment of blood–brain barrier (BBB) disruption as reflected by contrast enhancement after application of paramagnetic contrast media. In gliomas of World Health Organization (WHO) grades II and III, which are frequently non-enhancing, estimation of tumor extent relies on signal abnormalities in T2-weighted MRI or in the fluid-attenuated inversion recovery (FLAIR) sequence. It is well known, however, that neither contrast enhancement nor FLAIR abnormalities are specific for neoplastic tissue....
536 _ _ |a 572 - (Dys-)function and Plasticity (POF3-572)
|0 G:(DE-HGF)POF3-572
|c POF3-572
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Galldiks, Norbert
|0 P:(DE-Juel1)143792
|b 1
|u fzj
700 1 _ |a Lohmann, Philipp
|0 P:(DE-Juel1)145110
|b 2
|u fzj
773 _ _ |a 10.1093/neuonc/noz236
|g p. noz236
|0 PERI:(DE-600)2094060-9
|n 3
|p 313-314
|t Neuro-Oncology
|v 22
|y 2020
|x 1523-5866
856 4 _ |y Published on 2019-12-20. Available in OpenAccess from 2020-12-20.
|u https://juser.fz-juelich.de/record/868439/files/Langen_Post%20Print_2019_Neuro-Oncol_Combined%20PET%20PET_ADC%20mapping.pdf
856 4 _ |u https://juser.fz-juelich.de/record/868439/files/noz236.pdf
|y Restricted
856 4 _ |y Published on 2019-12-20. Available in OpenAccess from 2020-12-20.
|x pdfa
|u https://juser.fz-juelich.de/record/868439/files/Langen_Post%20Print_2019_Neuro-Oncol_Combined%20PET%20PET_ADC%20mapping.pdf?subformat=pdfa
856 4 _ |x pdfa
|u https://juser.fz-juelich.de/record/868439/files/noz236.pdf?subformat=pdfa
|y Restricted
909 C O |o oai:juser.fz-juelich.de:868439
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)131777
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-Juel1)143792
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 2
|6 P:(DE-Juel1)145110
913 1 _ |a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|1 G:(DE-HGF)POF3-570
|0 G:(DE-HGF)POF3-572
|2 G:(DE-HGF)POF3-500
|v (Dys-)function and Plasticity
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2020
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a Embargoed OpenAccess
|0 StatID:(DE-HGF)0530
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NEURO-ONCOLOGY : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b NEURO-ONCOLOGY : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 0
920 1 _ |0 I:(DE-Juel1)INM-4-20090406
|k INM-4
|l Physik der Medizinischen Bildgebung
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 _ _ |a I:(DE-Juel1)INM-4-20090406
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21